Does tranexamic acid reduce risk of mortality on patients with hemoptysis?: A protocol for systematic review and meta-analysis

BACKGROUND: Although tranexamic acid (TXA), a readily accessible antifibrinolytic agent, is widely adopted in hemorrhage scenarios, its role on mortality in patients with hemoptysis remains uncertain. New evidence is yet to be generated to evaluate the risk of mortality after using TXA in patients w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Medicine (Baltimore)
Huvudupphovsmän: Chen, Liang-Fu, Wang, Ting-Cheng, Lin, Ting-Yi, Pao, Po-Jia, Chu, Karen Chia-Wen, Yang, Chih-Hao, Chang, Jer-Hwa, Hsu, Chin-Wang, Bai, Chyi-Huey, Hsu, Yuan-Pin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2021
Ämnen:
3900
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137080/
https://ncbi.nlm.nih.gov/pubmed/34011056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025898
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk